Validity of death certificates in the identification of cases of amyotrophic lateral sclerosis (ALS) in the Limousin region, France. A population-based study

References

• Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6–11.
   PubMed Web of Science ®Google Scholar
• Marin B, Boumédiene F, Logroscino G, Couratier P, Babron MC, Leutenegger AL, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2016;46:57–74.
   Web of Science ®Google Scholar
• Marin B, Hamidou B, Couratier P, Nicol M, Delzor A, Raymondeau M, et al. Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe – the French register of ALS in Limousin (FRALim register). Eur J Neurol. 2014;21:1292–e79.
   PubMed Web of Science ®Google Scholar
• van Walraven C, Bennett C, Forster AJ. Administrative database research infrequently used validated diagnostic or procedural codes. J Clin Epidemiol. 2011;64:1054–9.
   PubMed Web of Science ®Google Scholar
• Nissen F, Quint JK, Morales DR, Douglas IJ. How to validate a diagnosis recorded in electronic health records. Breathe 2019;15:64–8.
   Web of Science ®Google Scholar
• Barash JA, West JK, DeMaria A. Jr. Accuracy of administrative diagnostic data for pathologically confirmed cases of Creutzfeldt-Jakob disease in Massachusetts, 2000–2008. Am J Infect Control. 2014;42:659–64.
   PubMed Web of Science ®Google Scholar
• Bogliun G, Beghi E. Validity of hospital discharge diagnoses for public health surveillance of the Guillain-Barre syndrome. Neurol Sci. 2002;23:113–7.
   PubMed Web of Science ®Google Scholar
• Chio A, Ciccone G, Calvo A, Vercellino M, Di Vito N, Ghiglione P, et al. Validity of hospital morbidity records for amyotrophic lateral sclerosis. A population-based study. J Clin Epidemiol. 2002;55:723–7.
   PubMed Web of Science ®Google Scholar
• Beghi E, Logroscino G, Micheli A, Millul A, Perini M, Riva R, et al. Validity of hospital discharge diagnoses for the assessment of the prevalence and incidence of amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis and other motor neuron disorders: official publication of the World Federation of Neurology. Res Group Motor Neuron Dis. 2001;2:99–104.
   Google Scholar
• Chancellor AM, Swingler RJ, Fraser H, Clarke JA, Warlow CP. Utility of Scottish morbidity and mortality data for epidemiological studies of motor neuron disease. J Epidemiol Commun Health. 1993;47:116–20.
   PubMed Web of Science ®Google Scholar
• Vasta R, Boumediene F, Couratier P, Nicol M, Nicoletti A, Preux PM, et al. Validity of medico-administrative data related to amyotrophic lateral sclerosis in France: a population-based study. Amyotr Lateral Scler Front Degener. 2017;18:24–31.
   PubMed Web of Science ®Google Scholar
• Durrleman S, Alperovitch A. Increasing trend of ALS in France and elsewhere: are the changes real? Neurology 1989;39:768–73.
   PubMed Web of Science ®Google Scholar
• Jougla E, Pavillon G, Rossollin F, De Smedt M, Bonte J. Improvement of the quality and comparability of causes-of-death statistics inside the European Community. EUROSTAT task force on “causes of death statistics”. Rev Epidemiol Sante Publique. 1998;46:447–56.
   PubMed Web of Science ®Google Scholar
• Marin B, Couratier P, Preux PM, Logroscino G. Can mortality data be used to estimate amyotrophic lateral sclerosis incidence? Neuroepidemiology 2011;36:29–38.
   PubMed Web of Science ®Google Scholar
• Johansen C, Olsen JH. Mortality from amyotrophic lateral sclerosis, other chronic disorders, and electric shocks among utility workers. Am J Epidemiol. 1998;148:362–8.
   PubMed Web of Science ®Google Scholar
• Insee. Institut national de la statistique et des études économiques. Estimation de la population au 1er Janvier par région, dèpartement (1975–2012), gender and age. internet2013 [cited 2019]. Available at: https://www.insee.fr/fr/statistiques.
   Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Chiò A, Magnani C, Oddenino E, Tolardo G, Schiffer D. Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis. J Epidemiol Commun Health. 1992;46:517–8.
   PubMed Web of Science ®Google Scholar
• Yeo L, Lynch C, Hardiman O. Validating population-based registers for ALS: how accurate is death certification? J Neurol. 2010;257:1235–9.
   PubMed Web of Science ®Google Scholar
• Stickler DE, Royer JA, Hardin JW. Accuracy and usefulness of ICD-10 death certificate coding for the identification of patients with ALS: results from the South Carolina ALS Surveillance Pilot Project. Amyotroph Lateral Scler. 2012;13:69–73.
   PubMed Web of Science ®Google Scholar
• Kioumourtzoglou MA, Seals RM, Himmerslev L, Gredal O, Hansen J, Weisskopf MG. Comparison of diagnoses of amyotrophic lateral sclerosis by use of death certificates and hospital discharge data in the Danish population. Amyotroph Lateral Scler Front Degener. 2015;16:224–9.
   PubMed Web of Science ®Google Scholar
• Marin B, Fontana A, Arcuti S, Copetti M, Boumediene F, Couratier P, et al. Age-specific ALS incidence: a dose-response meta-analysis. Eur J Epidemiol. 2018;33:621–34.
   PubMed Web of Science ®Google Scholar
• Gallo V, Bueno-De-Mesquita HB, Vermeulen R, Andersen PM, Kyrozis A, Linseisen J, et al. Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort. Ann Neurol. 2009;65:378–85.
   PubMed Web of Science ®Google Scholar
• Gallo V, Wark PA, Jenab M, Pearce N, Brayne C, Vermeulen R, et al. Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis. EPIC Cohort. 2013;80:829–38.
   Google Scholar
• Gallo V, Vanacore N, Bueno-de-Mesquita HB, Vermeulen R, Brayne C, Pearce N, et al. Physical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort study. Eur J Epidemiol. 2016;31:255–66.
   PubMed Web of Science ®Google Scholar
• Doyle P, Brown A, Beral V, Reeves G, Green J. Incidence of and risk factors for Motor Neurone Disease in UK women: a prospective study. BMC Neurol. 2012;12:25.
   PubMed Web of Science ®Google Scholar